Poly Medicure Limited (POLYMED.BO)
INR 2628.7
(-3.48%)
INR 2628.7
(-3.48%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 2.68 Billion | 1.9 Billion | 1.23 Billion | 1.18 Billion | 1.28 Billion | 1.06 Billion |
| Net Income | 2.58 Billion | 2.37 Billion | 1.95 Billion | 1.8 Billion | 1.25 Billion | 986.75 Million |
| Depreciation & Amortization | 639.26 Million | 571.66 Million | 539.52 Million | 475.22 Million | 405.27 Million | 372.92 Million |
| Deferred income taxes | - | -19.27 Million | -9.31 Million | -6.47 Million | -1.38 Million | -1.86 Million |
| Stock-based compensation | 21.14 Million | 19.27 Million | 9.31 Million | 6.47 Million | 1.38 Million | 1.86 Million |
| Change in working capital | -406.57 Million | -499.56 Million | -633.94 Million | -611.85 Million | -120.71 Million | -86.94 Million |
| Other non-cash items | 1.6 Billion | -538.75 Million | -623.3 Million | -476.58 Million | -258.75 Million | -207.91 Million |
| Investing Cash Flow | -2.54 Billion | -1.79 Billion | -853.31 Million | -4.35 Billion | -1.07 Billion | -1 Billion |
| Investments in PPE | -2.77 Billion | -2.39 Billion | -1.55 Billion | -951.31 Million | -1.06 Billion | -779.97 Million |
| Acquisitions | 19.16 Million | 1.47 Million | 15.14 Million | 6.14 Million | 3.4 Million | 24.1 Million |
| Investment purchases | - | 23.47 Million | - | -3.44 Billion | -150 Million | -382.97 Million |
| Sales/Maturities of investments | 204.42 Million | 577.63 Million | 645.43 Million | - | 81.82 Million | 100.32 Million |
| Other Investing Activities | 360.77 Million | -1000.00 | 41.88 Million | 33.62 Million | 52.41 Million | 31.14 Million |
| Financing Cash Flow | -91.29 Million | -125.05 Million | -353.37 Million | 3.16 Billion | -205.06 Million | -51.29 Million |
| Debt repayment | -211.19 Million | -209.89 Million | -62.81 Million | -664.51 Million | -332.94 Million | -282.41 Million |
| Dividends payments | -287.4 Million | -239.73 Million | -239.15 Million | - | -424.74 Million | -211.92 Million |
| Common Stock Repurchased | - | 419.79 Million | - | - | 665.89 Million | -122.28 Million |
| Common Stock Issuance | 2.63 Million | 3.51 Million | 989 Thousand | 4 Billion | 503 Thousand | 503 Thousand |
| Other Financing Activities | -107.6 Million | -98.73 Million | -52.39 Million | -165.99 Million | -113.77 Million | 564.82 Million |
| Accounts receivables | -366.85 Million | -287.96 Million | -507.35 Million | -338.62 Million | 58.99 Million | -187.7 Million |
| Accounts payables | 37.61 Million | 37.69 Million | 247.01 Million | 595 Thousand | 102.02 Million | 135.42 Million |
| Inventory | -123.75 Million | -402.9 Million | -418.82 Million | -143.87 Million | -283.04 Million | -108.01 Million |
| Other working capital | 46.42 Million | 153.61 Million | 45.22 Million | -129.95 Million | 1.3 Million | 73.35 Million |
| Cash at beginning of period | 74.31 Million | 77.57 Million | 49.54 Million | 48.57 Million | 43.17 Million | 37 Million |
| Cash at end of period | 1.46 Billion | 70.62 Million | 77.57 Million | 49.54 Million | 48.57 Million | 43.17 Million |
| Capital Expenditure | -2.77 Billion | -2.39 Billion | -1.55 Billion | -951.31 Million | -1.06 Billion | -779.97 Million |
| Effect of forex changes on cash | - | - | 1000.00 | -1000.00 | - | - |
| Net cash flow / Change in cash | 1.39 Billion | -6.95 Million | 28.02 Million | 972 Thousand | 5.39 Million | 6.16 Million |
| Free Cash Flow | -82.38 Million | -484.48 Million | -321.05 Million | 236 Million | 222.82 Million | 284.85 Million |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 740.39 Million | 683.57 Million | 2.58 Billion | 650.15 Million | 621.89 Million | 626.95 Million |
| Depreciation & Amortization | - | - | 639.26 Million | 162.11 Million | 159.9 Million | 155.24 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | 21.14 Million | - | - | - |
| Change in working capital | - | - | -406.57 Million | - | - | - |
| Other non-cash items | -740.39 Million | -683.57 Million | 1.6 Billion | -650.15 Million | -621.89 Million | -626.95 Million |
| Investing Cash Flow | - | - | -2.54 Billion | - | - | - |
| Investments in PPE | - | - | -2.77 Billion | - | - | - |
| Acquisitions | - | - | 19.16 Million | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | 204.42 Million | - | - | - |
| Other Investing Activities | - | - | 360.77 Million | - | - | - |
| Financing Cash Flow | - | - | -91.29 Million | - | - | - |
| Debt repayment | - | - | -211.19 Million | - | - | - |
| Dividends payments | - | - | -287.4 Million | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 2.63 Million | - | - | - |
| Other Financing Activities | - | - | -107.6 Million | - | - | - |
| Accounts receivables | - | - | -366.85 Million | - | - | - |
| Accounts payables | - | - | 37.61 Million | - | - | - |
| Inventory | - | - | -123.75 Million | - | - | - |
| Other working capital | - | - | 46.42 Million | - | - | - |
| Cash at beginning of period | - | - | 74.31 Million | 1.46 Billion | 839.22 Million | 74.31 Million |
| Cash at end of period | - | - | 1.46 Billion | 650.15 Million | 1.46 Billion | 626.95 Million |
| Capital Expenditure | - | - | -2.77 Billion | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | - | 1.39 Billion | -810.95 Million | 621.89 Million | 552.64 Million |
| Free Cash Flow | - | - | -82.38 Million | 650.15 Million | 621.89 Million | 626.95 Million |
IFSUF
CSPI
JYNT
0295
FISB
BAJAJHCARE